- Home
- SVRA vs ORC Comparison
SVRA vs ORC Comparison
Compare SVRA & ORC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- ORC
- Stock Information
- Founded
- SVRA N/A
- ORC 2010
- Country
- SVRA United States
- ORC United States
- Employees
- SVRA N/A
- ORC N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- ORC Real Estate Investment Trusts
- Sector
- SVRA Health Care
- ORC Real Estate
- Exchange
- SVRA Nasdaq
- ORC Nasdaq
- Market Cap
- SVRA 540.6M
- ORC 623.6M
- IPO Year
- SVRA N/A
- ORC 2013
- Fundamental
- Price
- SVRA $2.80
- ORC $8.03
- Analyst Decision
- SVRA Buy
- ORC Buy
- Analyst Count
- SVRA 7
- ORC 2
- Target Price
- SVRA $9.86
- ORC $9.50
- AVG Volume (30 Days)
- SVRA 966.0K
- ORC 2.6M
- Earning Date
- SVRA 03-06-2025
- ORC 01-30-2025
- Dividend Yield
- SVRA N/A
- ORC 17.93%
- EPS Growth
- SVRA N/A
- ORC N/A
- EPS
- SVRA N/A
- ORC 1.01
- Revenue
- SVRA N/A
- ORC $75,695,000.00
- Revenue This Year
- SVRA N/A
- ORC N/A
- Revenue Next Year
- SVRA N/A
- ORC N/A
- P/E Ratio
- SVRA N/A
- ORC $7.93
- Revenue Growth
- SVRA N/A
- ORC N/A
- 52 Week Low
- SVRA $2.60
- ORC $7.41
- 52 Week High
- SVRA $5.70
- ORC $9.08
- Technical
- Relative Strength Index (RSI)
- SVRA 39.71
- ORC 59.14
- Support Level
- SVRA $2.60
- ORC $7.47
- Resistance Level
- SVRA $3.14
- ORC $8.03
- Average True Range (ATR)
- SVRA 0.17
- ORC 0.14
- MACD
- SVRA -0.01
- ORC 0.02
- Stochastic Oscillator
- SVRA 32.79
- ORC 88.89
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc invests in residential mortgage-backed securities (RMBS) across the United States. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.